| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 88.2 | 21.8 | 90.5 |
| Other income | 0.6 | 0.1 | 0.5 |
| Total income | 88.7 | 22.0 | 90.9 |
| Profit before exceptional items & tax | 13.8 | 0.3 | 16.5 |
| Profit before tax | 13.8 | 0.3 | 16.5 |
| Net profit | 11.6 | 0.2 | 14.5 |
| Operating margin | 15.6% | 1.4% | 18.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -20.00% |
|---|---|
| Net profit, quarter on quarter | +5700.00% |
| Revenue, year on year | -2.50% |
NSE results filing, NSE: SHEEL. Figures extracted from the filing.
Sheel Biotech Ltd: key numbers
- Share price
- ₹61.50
- Market cap
- ₹125.2 Cr
- Revenue (annual)
- ₹110.0 Cr
- Net profit (annual)
- ₹11.76 Cr
- P/E (TTM)
- 10.7×Sector 40.4×
- Promoter holding
- 72.29%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sheel Biotech Ltd
All →Sheel Biotech Legal & Regulatory
SEBI issued an advisory letter to Sheel Biotech Limited for delayed disclosure of a monitoring agency report. No monetary penalty or restrictions were imposed on the company.
Sheel Biotech Annual General Meeting
Sheel Biotech Limited held its 35th Annual General Meeting on September 24, 2026. The meeting covered adoption of financial statements and approval of other ordinary resolutions.
Sheel Biotech Other Announcement
Sheel Biotech intimated that its Statutory Auditor Shyam Sunder Mangla & Co LLP has changed its name to S S Mangla & Co LLP effective 18 December 2025. No change in the auditor appointment itself.
Sheel Biotech Bags ₹14.53 Cr Order
Sheel Biotech Limited has finalised a commercial transaction for its Blueberry project, valued at ₹14.53 Crore. This contract marks a significant business development for the company.
- Value
- ₹14.53 Cr
Sheel Biotech Annual General Meeting
Sheel Biotech Limited scheduled its 35th Annual General Meeting for September 24, 2026. The company also announced the record date and book closure period.
Sheel Biotech Other Announcement
Sheel Biotech Limited submitted the Monitoring Agency Report for the half-year ended March 31, 2026, detailing the utilization of IPO proceeds as per SEBI regulations.